willard h dere md  radius board of directors  back to board of directors willard h dere md willard h dere md has served on our board of directors since november  and is also a member of the board of ocera therapeutics inc dr dere has been executive director of personalized health at the university of utah health sciences center and a professor of medicine in the school of medicine since november  prior to that he served at amgen inc a biopharmaceutical company as the senior vice president global development from december  to june  and from april  to october  and as international chief medical officer from january  to april  before he joined amgen in  dr dere served as vice president of endocrine bone and general medicine research and development at eli lilly and company a biopharmaceutical company where he also held various other roles in clinical pharmacology regulatory affairs and both earlystage translational and latestage clinical research dr dere received ba degrees in history and zoology and a md degree from the university of california davis we believe mr dere is qualified to serve as a member of our board of directors because of his strong medical background and extensive experience in the pharmaceutical industry × external link you are now leaving a radius health controlled website radius health does not endorse and is not responsible for the accuracy content practices procedures or standards of any nonradius health websites cancel continue dr willard h dere appointed to biomarin pharmaceutical inc board skip to main content login username  password  go  forgot password not a subscriber search form search toggle navigation dr willard h derehead program in personalized health university of utahsalt lake city utdr dere returned in  to the university of utah from amgen pharmaceuticals where he served for  years in numerous executive positions including head of global development and international chief medical officer previously he was a faculty member at the universitys school of medicine  fourth quarteradded to biomarin pharmaceutical inc  san rafael cabiomarin products address serious diseases and medical conditions revenues are  million willard h dere of biomarin pharmaceutical inc board of directors   welcome company news company site premium log in membership home portfolio stocks bonds funds etfs cef markets tools real life finance discuss investing ideas fund analyst picks picks by category fund pick performance picks  pans enewsletter fund spy column fund spy book bond squad fund video reports fundinvestor newsletter etf investing fund family experts fund reports all fund analyst reports fund stewardship reports fund ratings highestrated value highestrated growth highestrated largecap highestrated midcap highestrated smallcap foreign fund standouts star rating performance rating methodology fund performance top month performers top ytd performers top year performers top year performers top year performers fund category returns biggest daily nav changes closedend funds exchangetraded funds quarterly market outlook fund screeners basic screeners fund screener longterm winners solid smallgrowth funds conservative bond funds premium screeners premium fund screener index funds hidden gems lowerrisk foreign funds video center biomarin pharmaceutical inc  bmrn add to portfolioget email alertsprint this pagepdf reportdata questionquotechartstock analysisperformancekey ratiosfinancialsvaluationinsidersownershipfilingsbondsoverviewexecutive compensationinsider activitykey executivesboard of directorscommittees board of directors  willard h dere willard h dere independent director profile connections biography willard dere md joined our board in july  since november  he has served as the professor of internal medicine b lue and hope s bettilyon presidential endowed chair in internal medicine for diabetes research executive director of personalized health and coprincipal investigator of the center for clinical and translational science at the university of utah health sciences center prior to rejoining academia in november  dr dere was in the biopharmaceutical industry for  years from  until his retirement in  dr dere held multiple roles at amgen inc a biotechnology company including serving as head of global development and both international and corporate chief medical officer from december  to october  he began his career at eli lilly in  and held a number of different global roles in clinical pharmacology regulatory affairs and both earlystage translational and late stage clinical research since  he has been a member of the board of directors for radius health and has served on the scientific advisory board of the california institute of regenerative medicine he joined the board of ocera therapeutics in october  dr dere received a ba and an md from the university of california davis he trained in internal medicine at the university of utah and endocrinologymetabolism at the university of california at san francisco board membership company name board member since board committees biomarin pharmaceutical inc  boardcorporate governance and nominatingscience and technology ocera therapeutics inc  board radius health inc  auditboardnominating and corporate governance willard h dere is connected to  board memberssee list of all board connections   we value your feedback let us know what you think site directory site map our products corrections help advertising opportunities licensing opportunities glossary rss mobile portfolio affiliate careers international sites australia canada china france germany hong kong italy the netherlands norway spain uk switzerland stocks by name  ticker  star rating  market cap  stock type  sector  industry mutual funds by star rating  investment style  total assets  category  top holdings  top sectors  symbol  ticker  name etfs by star rating  category  total assets  symbol  ticker  name articles by title  date  author  collection  interest  popularity investment categories by topic  sector  key indicators  user interest  market cap  industry premium stocks by name  ticker  star rating  market cap  stock type  sector  industry premium mutual funds by star rating  investment style  total assets  category  top holdings  top sectors  symbol  ticker  name premium etfs by star rating  category  total assets  symbol  ticker  name popular articles by title  date  author  collection  interest  popularity popular investment categories by topic  sector  key indicators  user interest  market cap  industry independent insightful trusted morningstar provides stock market analysis equity mutual fund and etf research ratings and picks portfolio tools and option hedge fund ira k and  plan research our reliable data and analysis can help both experienced enthusiasts and newcomers  copyright morningstar inc all rights reserved please read our terms of useand privacy policydow jones industrial average sp  nasdaq and morningstar index market barometer quotes are realtime russell  quote is  minutes delayed willard h dere md to lead program in personalized health search doctors services locations patients  visitors mychart public affairs  news  announcements    october  willard h dere md to lead program in personalized health willard h dere md to lead program in personalized health print media contactswillard h dere md to lead program in personalized healthwillard h dere mdoct    pmsalt lake city—an internationally regarded medical researcher and leader in the biopharmaceutical industry and former university of utah school of medicine faculty member and medical resident will h dere md facp will return to the university to lead the program in personalized health beginning nov  dere comes to the university from amgen one of the world’s largest biopharmaceutical companies where he has served in numerous executive positions including head of global development head of international medical corporate chief medical officer and international chief medical officer over an year period  before that at eli lilly he served in numerous senior positions in endocrine research and development regulatory affairs and translational medicine  during his  years in the pharma industry dere had the opportunity to lead the clinical development of three boneactive medicines raloxifene rpth  and denosumab and several others in the oncology inflammation and nephrology therapeutic areas  “there are immense opportunities with ongoing and planned initiatives here at the university of utah to enhance our understanding of the genome and molecular biology and to use this knowledge in a wise manner to individualize health care interventions” dere says “i am delighted and honored by this opportunity to participate in these initiatives and to work again with smart collaborative colleagues at the university of utah” vivian s lee md phd mba university of utah u of u senior vice president for health sciences said dere’s expertise in pharmaceutics as well as his experience at the university position him well to lead the personalized health program “as a recognized leader in translation of genomic discovery to improved clinical care dr dere can build on our strengths to develop a personalized health initiative that will transform the way we practice health care” she says accepting the position in personalized health represents a homecoming for dere who received his internal medicine residency training at the u of u school of medicine after further training in endocrinology and metabolism at the university of california san francisco he returned to the u of u to join the medical school faculty where he held a hospital appointment at the veterans affairs salt lake city health system      media contactsphil sahmpublic affairs office phone   email philsahmhscutaheduvisit our news archive for a complete list of previous news public affairs homenews  announcementsevents calendarin the news nobel laureate mario capecchipublicationsmedia contacts willard dere  eli lilly and company  zoominfocom ocrx willard h dere insider trades for ocera therapeutics inc bulletin investor alert tokyo markets open in us market snapshot currencies commodities expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close ocera therapeutics inc nasdaq ocrx go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus ocera therapeutics inc market closed  quotes are delayed by  min jul    pm ocrx quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual willard h dere dr willard h dere md is professormedicine at university of utah school of medicine and executive directorpersonalized health at the university of utah health sciences center he is on the board of directors at ocera therapeutics inc biomarin pharmaceutical inc and radius health inc dr dere was previously employed as chief medical officer  svpglobal development by amgen inc and a principal by eli lilly  co he received his undergraduate degree from the university of california davis and a doctorate degree from the university of california davis transactions date shares transaction value     award at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives dr linda s grais president chief executive officer  director mr michael byrnes chief financial  principal accounting officer dr stan bukofzer chief medical officer ms amy potthoff vice presidentclinical operations dr mark coffin vppharmaceutical development  manufacturing dr willard h dere director ms susan p sharpe investor relations contact dr eckard weber chairman mr steven p james lead independent director dr wendell d wierenga independent director ms nina sofia kjellson independent director ms anne m vanlent independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite tlt quoteszigmancomposite jnug x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pat least  dead after overheated tractortrailer found outside texas walmart p‘full transparency’ doesn’t mean what scaramucci apparently thinks it means pstocks brace for volatility in earnings deluge fed meeting looms pthe dark side of cruises pif you suddenly quit your job like sean spicer here’s what you should do next pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pnever ever say these things to a coworker pmy uncle with dementia needs longterm care — should i refinance his house pthis is the deadliest time of your life to put on weight p easily avoidable reasons why millennials can’t have nice things or save any money pwhy house prices in gay neighborhoods are soaring pnearly  of adults don’t have life insurance — these startups are trying to change that pmarie kondo says this one thing could be holding you back from falling in love pthis luxury credit card is only for truly big spenders phow elon musk and shorter commutes could transform people’s lives pbanks have raised creditcard interest rates — but not savings account rates pthe most expensive city in the world is not new york or san francisco p in  americans say they will die in debt pshopping at costco and  other things that prove rich people are cheap aheavy showers swamp new orleans street with rainwater loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  willard h dere  researcher profile  symptomacom close login email password login forgot password willard h dere research topics by  publications citations   • diseases x osteoporosis x rheumatic diseases x rheumatic fever x endocrine system diseases x genetic predisposition to disease register to see all go coauthor network coauthor  copublications coauthor  copublications bruce h mitlak  eric c abadie  bernard p avouac  dominique j ethgen  andrea laslop  yannis tsouderos  roy d altman  thomas bardin  maarten boers  gilles m bouvenot  jaime branco  register to see all go publications top   referenced the role of pharmacogenetics and pharmacogenomics in improving translational medicine  ts suto pharmacogenomics in endocrinology  rd hockett sc kirkwood bh mitlak recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoidinduced osteoporosis updated recommendations from the group for the respect of ethics and excellence in science  ec abadie rd altman  bp avouac gm bouvenot j branco pd delmas jp devogealer dj ethgen g kreutz a laslop cj menkès bh mitlak jj orloff jy reginster jd ringe y tsouderos pm vanderauwera l vanhaelst recommendations for an update of  european regulatory requirements for registration of drugs to be used in the treatment of ra  group for respect of ethics and excellence in science grees ec abadie  bp avouac t bardin m boers fc breedveld p durez p emery dj ethgen b flamion n goel a laslop fj lekkerkerker m matuccicerinic p miossec bh mitlak s ormarsdottir l paolozzi r rao jy reginster s reiter js smolen y tsouderos register to see all go institutes institute institute register to see all go no map available title and abstract from medline®pubmed® a database of the us national library of medicinedata mined from medline®pubmed® a database of the us national library of medicine last medline®pubmed® update st of december  symptoma examples subscribe login close please enter your email address to search again continue physician patient insider trading  dere willard h  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  dere willard h select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing option award  am na ocera therapeutics inc ocrx dere willard hdirector   direct view option award  pm nana biomarin pharmaceutical inc bmrn dere willard hdirector   direct view option award  pm  biomarin pharmaceutical inc bmrn dere willard hdirector   direct view option award  pm nana biomarin pharmaceutical inc bmrn dere willard hdirector   direct view option award  pm  biomarin pharmaceutical inc bmrn dere willard hdirector   direct view option award  am na radius health inc rdus dere willard hdirector   direct view option award  pm na radius health inc rdus dere willard hdirector   direct view option award  pm na radius health inc rdus dere willard hdirector   direct view   secformcom all rights reserved archives        sun  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  generic forteo availability  drugscom skip to content search all allconsumerprofessionalpill idinteractionsnewsfda alertsapprovalspipelineclinical trialscare notesencyclopediadictionarynatural products browse all medications a b c d e f g h i j k l m n o p q r s t u v w x y z advanced search topics  tools facebook twitter google plus sign in sign in register menu home › generic drugs › forteo print share generic forteo availability forteo is a brand name of teriparatide approved by the fda in the following formulations forteo teriparatide recombinant human  injectablesubcutaneous manufacturer lilly approval date november   strengths mgml mgml manufacturer lilly approval date june   strengths mgml mgml rld has a generic version of forteo been approved no there is currently no therapeutically equivalent version of forteo available in the united states note fraudulent online pharmacies may attempt to sell an illegal generic version of forteo these medications may be counterfeit and potentially unsafe if you purchase medications online be sure you are buying from a reputable and valid online pharmacy ask your health care provider for advice if you are unsure about the online purchase of any medicationsee also about generic drugs related patents patents are granted by the us patent and trademark office at any time during a drugs development and may include a wide range of claims stabilized teriparatide solutionspatent issued august  inventors chinming chang  henry a havelassignees eli lilly and companya stabilized pharmaceutical composition in the form of a solution for parenteral administration of a parathyroid hormone is described wherein the therapeutically active ingredient is stabilized with a buffer and a polyol preferred preparations contain in an aqueous solution human pth mannitol an acetate or tartrate buffering agent and mcresol or benzyl alcohol as a preservativepatent expiration dates december  ✓ patent use a method of treating osteoporosis✓ drug product december  ✓ patent use forteo is indicated for the treatment of post menopausal women with osteoporosis who are at high risk for fracture✓ drug product method of increasing bone toughness and stiffness and reducing fracturespatent issued december  inventors hock janet m  gaich gregory a  dere willard hassignees eli lilly and companythe invention relates to a method for increasing the toughness andor stiffness of bone andor reducing the likelihood andor severity of bone fracture by administering a parathyroid hormone the method can be employed to increase toughness or stiffness of bone at a site of a potential or actual trauma such as the hip or spine of a person at risk of or suffering from osteoporosis the method of the invention can reduce the incidence of vertebral fracure reduce the incidence of multiple vertebral fractures reduce the severity of vertebral fracture andor reduce the incidence of nonvertebral fracturepatent expiration dates august  ✓ patent use a method of treating osteoporosis august  ✓ patent use method of treatment of osteoporosis wherein the osteoporosis is steroidinduced august  ✓ patent use forteo is indicated for the treatment of post menopausal women with osteoporosis who are at high risk for fracture stabilized teriparatide solutionspatent issued december  inventors chang chinming  havel henry aassignees eli lilly and companya stabilized pharmaceutical composition in the form of a solution for parenteral administration of a parathyroid hormone is described wherein the therapeutically active ingredient is stabilized with a buffer and a polyol preferred preparations contain in an aqueous solution human pth– mannitol an acetate or tartrate buffering agent and mcresol or benzyl alcohol as a preservativepatent expiration dates december  ✓ drug product method of increasing bone toughness and stiffness and reducing fracturespatent issued january  inventors gaich gregory a  dere willard h  hock janet massignees eli lilly and companythe invention relates to a method for increasing the toughness andor stiffness of bone andor reducing the likelihood andor severity of bone fracture by administering a parathyroid hormone the method can be employed to increase toughness or stiffness of bone at a site of a potential or actual trauma such as the hip or spine of a person at risk of or suffering from osteoporosis the method of the invention can reduce the incidence of vertebral fracture reduce the incidence of multiple vertebral fractures reduce the severity of vertebral fracture andor reduce the incidence of nonvertebral fracturepatent expiration dates august  ✓ patent use method of treating osteoporosis in a postmenopausal woman at risk for fracture august  ✓ patent use method of treatment of osteoporosis wherein the osteoporosis is steroidinduced august  ✓ patent use forteo is indicated for the treatment of post menopausal women with osteoporosis who are at risk for fracture forteo can be used by people who have had a fracture related to osteoporosis method of reducing the risk of bone fracturepatent issued april  inventors gaich gregory a  dere willard h  hock janet massignees eli lilly and companythe invention relates to a method for increasing the toughness andor stiffness of bone andor reducing the likelihood andor severity of bone fracture by administering a parathyroid hormone the method can be employed to increase toughness or stiffness of bone at a site of a potential or actual trauma such as the hip or spine of a person at risk of or suffering from osteoporosis the method of the invention can reduce the incidence of vertebral fracture reduce the incidence of multiple vertebral fractures reduce the severity of vertebral fractur andor reduce the incidence of nonvertebral fracturepatent expiration dates august  ✓ patent use method for the treatment of a woman with osteoporosis and at risk for bone fracture august  ✓ patent use method of treatment of osteoporosis wherein the osteoporosis is steroidinduced august  ✓ patent use treatment of a woman with osteoporosis and a high risk for bone fracture by reducing the risk of vertebral and nonvertebral bone fracture medication dispensing apparatus with springdriven locking feature enabled by administration of final dosepatent issued april  inventors jacobs alexander thomas  judson jared alden  row gordon davidsonassignees eli lilly and companya medication dispensing apparatus with a springdriven locking feature includes a drive member movable in a distal direction within a housing and a fluid container with a piston that is advanceable by the drive member  when such drive member is moved distally by a driving means the apparatus includes a latching element  having a skid  that is slidable along a surface of the drive member as the drive member passes distally during advancement the drive member is arranged with the skid so as to maintain a latching lip of the latching element against a spring force in a first position free of the driving means during dose preparing and injecting prior to a final dose administration the skidengaging surface shifts distally of the skid such that the skid passes beyond a proximal end of that surface upon administration of a final dose whereby the latching lip is urged by the spring force from the first position to a second position to physically lock the driving means to prevent further dose preparing and injectingpatent expiration dates march  ✓ drug product stabilized teriparatide solutionspatent issued june  inventors chang chinming  havel henry aassignees eli lilly and companya stabilized pharmaceutical composition in the form of a solution for parenteral administration of a parathyroid hormone is described wherein the therapeutically active ingredient is stabilized with a buffer and a polyol preferred preparations contain in an aqueous solution human pth mannitol an acetate or tartrate buffering agent and mcresol or benzyl alcohol as a preservativepatent expiration dates december  ✓ patent use a method of treating osteoporosis✓ drug product share on googleplus share on facebook share on twitter print this page email to a friend add to my med list more about forteo teriparatide side effects during pregnancy dosage information drug interactions support group pricing  coupons en español  reviews – add your own reviewrating drug class parathyroid hormone and analogs consumer resources forteo forteo advanced reading professional resources forteo ahfs monograph forteo fda related treatment guides osteoporosis glossary termdefinition drug patenta drug patent is assigned by the us patent and trademark office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation the patent assigns exclusive legal right to the inventor or patent holder and may include entities such as the drug brand name trademark product dosage form ingredient formulation or manufacturing process a patent usually expires  years from the date of filing but can be variable based on many factors including development of new formulations of the original chemical and patent infringement litigation drug exclusivityexclusivity is the sole marketing rights granted by the fda to a manufacturer upon the approval of a drug and may run simultaneously with a patent exclusivity periods can run from  days to seven years depending upon the circumstance of the exclusivity grant rlda reference listed drug rld is an approved drug product to which new generic versions are compared to show that they are bioequivalent a drug company seeking approval to market a generic equivalent must refer to the reference listed drug in its abbreviated new drug application anda by designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent fda hopes to avoid possible significant variations among generic drugs and their brand name counterpart drug status availability rx prescription only pregnancy category c risk cannot be ruled out csa schedule n not a controlled drug approval history calendar drug history at fda close forteo rating  user reviews   user reviews      rate it drug class parathyroid hormone and analogs recently approved vosevi vosevi sofosbuvir velpatasvir and voxilaprevir or sof  vel  vox is a fixeddose combination of a nerlynx nerlynx neratinib is a tyrosine kinase inhibitor for the extended adjuvant treatment of tremfya tremfya guselkumab is an interleukin blocker indicated for the treatment of moderatetosevere endari endari lglutamine is orallyadministered pharmaceutical grade lglutamine pglg an amino acid more fda consumer updates depression fdaapproved medications may help dealing with adhd what you need to know making decisions for your health getting the info you need fda cuttingedge technology sheds light on antibiotic resistance more fda updates related news and articles amgen and ucb receive complete response letter from us fda for evenity romosozumab bla july   could your office job rob you of vitamin d june   even your bones can get fat mouse study suggests june   drugscom mobile apps the easiest way to lookup drug information identify pills check interactions and set up your own personal medication records available for android and ios devices explore apps support help center frequent questions sitemap contact us about about drugscom advertising policy content submissions drugscom blog terms  privacy editorial policy privacy policy terms of use attribution  citations facebook twitter google plus youtube rss feed subscribe to receive email notifications whenever new articles are published drugscom provides accurate and independent information on more than  prescription drugs overthecounter medicines and natural products this material is provided for educational purposes only and is not intended for medical advice diagnosis or treatment data sources include micromedex® updated july th  cerner multum™ updated july th  wolters kluwer™ updated july th  and others to view content sources and attributions please refer to our editorial policy third party advertising we comply with the honcode standard for trustworthy health information  verify here copyright   drugscom all rights reserved share on facebook share on twitter share on googleplus email to a friend hide microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft loading your search results  peoplelookercom updating data on  live please help us narrow down your search all states alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming im not sure please enter a full name please help us narrow down your search first name please enter first name last name please enter last name people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again